Sponsored
Jeplus.in
Purchase All Medicines.Get 10% Offer
Pharma Tech
What Ojemda’s JCA reveals about new era of clinical HTA in Europe
An analysis of GlobalData’s Drug Pricing (POLI) & HTA database shows no HTA outcome for Ojemda in the wake of the JCA review.
Read Full Article
PharmaShots
Gona Aziz at HLTH Europe 2026 on the Convergence of AI & 5T MRI: United Imaging’s Strategy for Advancing Precision Healthcare
Shots Aditya: At HLTH Europe, United Imaging is highlighting the uMR Jupiter 5T and discussing the future of AI-enabled radiology. How do you see advanced imaging technologies and AI evolving together to reshape diagnostic decision-making? Gona: We see advanced imaging and AI evolving as two sides of the same transformation. Technologies like the uMR Jupiter 5T enable clinicians to capture… The post Gona Aziz at HLTH Europe 2026 on the Convergence of AI & 5T MRI: United Imaging’s Strategy for Advancing Precision Healthcare appeared first on PharmaShots.
Read Full Article
Express Pharma
Society for Pharma Quality Leaders organises SPQL Annual Meet 2026 in Hyderabad
National pharma quality leaders convene to advance evolving compliance standards The post Society for Pharma Quality Leaders organises SPQL Annual Meet 2026 in Hyderabad appeared first on Express Pharma.
Read Full Article
Express Pharma
Emcure to expand use of Poviztra for MASH indication after CDSCO nod
Poviztra® is manufactured and imported from Novo Nordisk's European manufacturing facility and contains innovator rDNA-origin semaglutide The post Emcure to expand use of Poviztra for MASH indication after CDSCO nod appeared first on Express Pharma.
Read Full Article
Pharma Tech
Novartis and Takeda drugs gain rare blood cancer routine use on NHS
The therapies’ availability will offer a route to personalised, mutation-specific approaches for types of rare blood cancers.
Read Full Article
Sponsored content
Featured promotional
News
Latest stories
Pharma Tech
Jul 20, 2026, 3:38 PM
What Ojemda’s JCA reveals about new era of clinical HTA in Europe
An analysis of GlobalData’s Drug Pricing (POLI) & HTA database shows no HTA outcome for Ojemda in the wake of the JCA review.
PharmaShots
Jul 20, 2026, 1:30 PM
Gona Aziz at HLTH Europe 2026 on the Convergence of AI & 5T MRI: United Imaging’s Strategy for Advancing Precision Healthcare
Shots Aditya: At HLTH Europe, United Imaging is highlighting the uMR Jupiter 5T and discussing the future of AI-enabled radiology. How do you see advanced imaging technologies and AI evolving together to reshape diagnostic decision-making? Gona: We see advanced imaging and AI evolving as two sides of the same transformation. Technologies like the uMR Jupiter 5T enable clinicians to capture… The post Gona Aziz at HLTH Europe 2026 on the Convergence of AI & 5T MRI: United Imaging’s Strategy for Advancing Precision Healthcare appeared first on PharmaShots.
ET Pharma
Jul 20, 2026, 1:05 PM
Bristol Myers buys Nvidia's latest AI computing system for drug research
The drugmaker said it will be the first life sciences company to buy an Nvidia DGX SuperPOD based on its Vera Rubin systems. The chipmaker unveiled its Vera Rubin architecture earlier this year as the successor to its current generation of AI computing systems.
Express Pharma
Jul 20, 2026, 12:30 PM
Society for Pharma Quality Leaders organises SPQL Annual Meet 2026 in Hyderabad
National pharma quality leaders convene to advance evolving compliance standards The post Society for Pharma Quality Leaders organises SPQL Annual Meet 2026 in Hyderabad appeared first on Express Pharma.
PharmaShots
Jul 20, 2026, 12:30 PM
Organon and Samsung Bioepis Expand Commercialisation Agreement to Broaden Biosimilar Access in Australia
Shots: Ref: Organon | Image: Organon & Samsung Bioepis | Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us atconnect@pharmashots.com The post Organon and Samsung Bioepis Expand Commercialisation Agreement to Broaden Biosimilar Access in Australia appeared first on PharmaShots.
Express Pharma
Jul 20, 2026, 12:20 PM
Emcure to expand use of Poviztra for MASH indication after CDSCO nod
Poviztra® is manufactured and imported from Novo Nordisk's European manufacturing facility and contains innovator rDNA-origin semaglutide The post Emcure to expand use of Poviztra for MASH indication after CDSCO nod appeared first on Express Pharma.
News
Latest industry coverage
Google News
Jul 20, 2026, 6:19 PM
Pharma industry’s next big leap - The Daily Star
Pharma industry’s next big leap The Daily Star
Google News
Jul 20, 2026, 6:03 PM
FDA Approves Merck Oral Pill for High Cholesterol - Mexico Business News
FDA Approves Merck Oral Pill for High Cholesterol Mexico Business News
Google News
Jul 20, 2026, 5:57 PM
Bristol Myers Squibb Expands Partnership with Nvidia | PharmExec - Pharmaceutical Executive
Bristol Myers Squibb Expands Partnership with Nvidia | PharmExec Pharmaceutical Executive
Google News
Jul 20, 2026, 5:46 PM
AI Is Supercharging Drug Development. The Tech is Slashing Early Research Costs and Timelines by Up to 70% - International Business Times
AI Is Supercharging Drug Development. The Tech is Slashing Early Research Costs and Timelines by Up to 70% International Business Times
Google News
Jul 20, 2026, 5:40 PM
Keeping drugs free of contaminants—pharmaceutical manufacturers filter medications through tiny pores - Medical Xpress
Keeping drugs free of contaminants—pharmaceutical manufacturers filter medications through tiny pores Medical Xpress
Google News
Jul 20, 2026, 5:37 PM
Supreme Court of Canada Upholds Prohibition on Medical Treatment Patents - The Manila Times
Supreme Court of Canada Upholds Prohibition on Medical Treatment Patents The Manila Times
Google News
Jul 20, 2026, 5:20 PM
Supreme Court of Canada Upholds Prohibition on Medical Treatment Patents - Yahoo Finance Singapore
Supreme Court of Canada Upholds Prohibition on Medical Treatment Patents Yahoo Finance Singapore
Google News
Jul 20, 2026, 4:53 PM
Clinigen Appoints Greg Skalicky as Chief Executive Officer - BioSpace
Clinigen Appoints Greg Skalicky as Chief Executive Officer BioSpace
Google News
Jul 20, 2026, 4:47 PM
Big Pharma And Psychedelic Medicine: Eli Lilly’s $3.8 Billion Bet - Forbes
Big Pharma And Psychedelic Medicine: Eli Lilly’s $3.8 Billion Bet Forbes
Sponsored placement
Featured promotions
Sponsored
Jeplus.in
Purchase All Medicines.Get 10% Offer